1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ULTRAGENYX PHARMACEUTICAL INC.
Ultragenyx Pharmaceutical Inc. XNAS: RARE
30.31 -0.92 (-2.95%)
1.4M
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Ultragenyx Pharmaceutical Inc. is on 23 Sep 2025 for the purpose of Bank of America Global Healthcare Conference See details

Ultragenyx Pharmaceutical Inc. - RARE - stock price prediction, stock price target, analyst ratings from 20 analysts

Ultragenyx Pharmaceutical Inc. has a share price target of US$ 87, revenue growth forecast of 17.4%, and profit growth estimate of 10.3% for FY25, based on top 20 analyst calls.